Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Bausch Health Companies Inc.BHC · Entity 4363 | SVP, Controller & CAO | July 14, 2026 | July 15, 2026 |
| MOHAWK INDUSTRIES INCMHK · Entity 3614 | CAO and Corporate Controller | March 04, 2022 | March 08, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Bausch Health Companies Inc.
Report date July 14, 2026 · Filed July 15, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Shares, No Par ValueSEC Table I · non-derivative | Direct | 70,114 |
Reported balance
After 2026-07-14 transaction · row 1
1 source rowRow 1 · 2026-07-14 · Tax withholding · Disposed 3,125 · Balance 70,114 F1: This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units. |
Filing footnotes · ownership attribution and instrument terms
F1: This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units.
MOHAWK INDUSTRIES INC
Report date March 04, 2022 · Filed March 08, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 3,285 |
Ending reported balance
After 2022-03-04 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2022-03-04 · Tax withholding · Disposed 91 · Balance 2,343 F1: Disposition related to meeting tax obligations upon vesting of restricted stock units. Row 2 · 2022-03-04 · Grant · Acquired 942 · Balance 3,285 |
Filing footnotes · ownership attribution and instrument terms
F1: Disposition related to meeting tax obligations upon vesting of restricted stock units.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 14, 2026 Filed Jul 15, 2026 21:20 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | Tax withholdingCommon Shares, No Par Value | 3,125 | $4.75 | $14,843.75 |
DisclosureSEC source: 0000885590-26-000097 · form4.xml · nonDerivative · entry 1 LEE STEVEN HYOSIG · CIK 0001855708 · SVP, Controller & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,114 F1 · shares: This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units. Read SEC document |
| February 25, 2026 Filed Feb 27, 2026 22:23 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 45,868 | $0.00 | $0.00 |
DisclosureSEC source: 0000885590-26-000035 · form4.xml · nonDerivative · entry 1 LEE STEVEN HYOSIG · CIK 0001855708 · SVP, Controller & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 73,239 F1 · shares: Represents the award of restricted share units ("RSUs") which will vest one-third on each of the first three anniversaries following the date of grant, subject to the reporting person's continued service. Vested RSUs are settled in common shares, no par value, of Bausch Health Companies Inc. Read SEC document |
| July 14, 2025 Filed Jul 15, 2025 21:18 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 27,371 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-019220 · form4.xml · nonDerivative · entry 1 LEE STEVEN HYOSIG · CIK 0001855708 · SVP, Controller & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,371 F1 · shares: Represents the award of restricted share units ("RSU s") which will vest one-third on each of the first three anniversaries following the date of grant, subject to the reporting person's continued service. Vested RSUs are settled in common shares, no par value, of Bausch Health Companies Inc. Read SEC document |
| March 04, 2022 Filed Mar 8, 2022 22:50 UTC | MOHAWK INDUSTRIES INC MHK · Entity 3614 | GrantCommon Stock | 942 | $0.00 | $0.00 |
DisclosureSEC source: 0000851968-22-000044 · edgardoc.xml · nonDerivative · entry 2 LEE STEVEN HYOSIG · CIK 0001855708 · CAO and Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,285 Read SEC document |
| March 04, 2022 Filed Mar 8, 2022 22:50 UTC | MOHAWK INDUSTRIES INC MHK · Entity 3614 | Tax withholdingCommon Stock | 91 | $137.35 | $12,498.85 |
DisclosureSEC source: 0000851968-22-000044 · edgardoc.xml · nonDerivative · entry 1 LEE STEVEN HYOSIG · CIK 0001855708 · CAO and Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,343 F1 · kind: Disposition related to meeting tax obligations upon vesting of restricted stock units. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.